semaglutide adverse reactions Frontiers Semaglutide Side Effects: Incidence Rates

The triple-agonist combination filings suggest AstraZeneca is positioning either for a combination-product strategy (a triple agonist co-formulated or co-packaged with an SGLT2 inhibitor, an amylin analog, or a calcitonin/amylin dual like cagrilintide) or for a licensing-target role where the combination claims would apply to partner products

Additionally, the oral Wegovy pill provides flexibility for those wishing to avoid injections, as it contains the same active component in a daily tablet form

FDA, not approved by the Philippines FDA (where its been formally restricted), and not approved by Indias CDSCO for cosmetic use

Generally I refer to both of these drugs as incretin medicines because they work to enhance natural gut hormones called incretins (GLP-1 and GIP)